Abstract Title:

Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.

Abstract Source:

Clin Exp Immunol. 2019 Aug 13. Epub 2019 Aug 13. PMID: 31407330

Abstract Author(s):

Cuihua Liu, Huazhen Liu, Chuanjian Lu, Jingwen Deng, Yuhong Yan, Haiming Chen, Yuanzhong Wang, Chun-Ling Liang, Jianan Wei, Ling Han, Zhenhua Dai

Article Affiliation:

Cuihua Liu


Psoriasis is an immune-mediated inflammatory skin disease that mainly affects the skin barrier. Treatment for psoriasis mainly includes conventional immunosuppressive drugs. However, long-term treatment with global immunosuppressive agents may cause a variety of side effects, including nephrotoxicity and infections. Kaempferol, a natural flavonol present in various plants, is known to possess potent anti-inflammatory, antioxidant and anti-cancerous properties. However, it's unknown whether kaempferol is also anti-psoriatic. Here we established an imiquimod (IMQ)-induced psoriatic mouse model to explore the potential therapeutic effects of kaempferol on psoriatic skin lesion and inflammation. In this study, we demonstrated that treatment with kaempferol protected mice from developing psoriasis-like skin lesion induced by topical administration of IMQ. Kaempferol reduced CD3T cell infiltration and gene expression of major proinflammatory cytokines, including IL-6, IL-17A and TNFα, in the psoriatic skin lesion. It also down-regulated proinflammatory NFκB signaling in the skin. The therapeutic effects were associated with a significant increase in CD4FoxP3Treg frequency in the spleen and lymph nodes as well as FoxP3-positive staining in the skin lesion. On the other hand, depletion of CD4CD25Tregs reversed the therapeutic effects of kaempferol on the skin lesion. Kaempferol also lowered the percentage of IL17ACD4T cells in the spleen and lymph nodes of IMQ-induced psoriatic mice. Finally, kaempferol suppressed the proliferation of T cells in vitro and their mTOR signaling as well. Thus, our findings suggest that kaempferol may be a therapeutic drug for treating human psoriasis in the near future. This article is protected by copyright. All rights reserved.

Study Type : Animal Study, In Vitro Study

Print Options

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2020 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.